Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.54 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ACE | P12821 | 7/20 | 0.49 |
| ▸ | CPA1 | P15085 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3799467 | 1.00 | FOLH1 (0.54) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL2703294 | 1.00 | FOLH1 (0.54) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL10494110 | 0.98 | FOLH1 (0.52) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL10494109 | 0.98 | FOLH1 (0.52) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| Trifluoroacetic Acid SCHEMBL29695528 | 0.92 | ACE (0.53) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL10537166 | 0.91 | FOLH1 (0.47) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL9052244 | 0.86 | FOLH1 (0.43) | FOLH1NAALAD2SLC7A5MMEMEN1 | |
| SCHEMBL697901 | 0.86 | EPHX1 (0.61) | FOLH1NAALAD2MMEMEN1KMT2A | |
| SCHEMBL697900 | 0.86 | EPHX1 (0.61) | FOLH1NAALAD2MMEMEN1KMT2A | |
| SCHEMBL8211678 | 0.86 | EPHX1 (0.61) | FOLH1NAALAD2MMEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105523964-B | Preparation method of anti-heart-failure drug intermediate | 苏州楚凯药业有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-105523964-A | Preparation method of anti-heart-failure drug intermediate | SUZHOU CHUKAI PHARMATECH CO LTD | 2016-04-27 | — | — | CN | claimed |
| EP-1621546-B1 | Peptide ligands specific to immonoglobulins | TECNOGEN SPA (IT) | 2008-10-29 | — | — | EP | claimed |
| EP-1621546-A1 | Peptide ligands specific to immonoglobulins | TECNOGEN S.C.P.A. (IT) | 2006-02-01 | — | — | EP | claimed |
| CN-105523964-B | Preparation method of anti-heart-failure drug intermediate | 苏州楚凯药业有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-105523964-B | Preparation method of anti-heart-failure drug intermediate | 苏州楚凯药业有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-105523964-A | Preparation method of anti-heart-failure drug intermediate | SUZHOU CHUKAI PHARMATECH CO LTD | 2016-04-27 | — | — | CN | disclosed |
| CN-105523964-A | Preparation method of anti-heart-failure drug intermediate | SUZHOU CHUKAI PHARMATECH CO LTD | 2016-04-27 | — | — | CN | disclosed |
| CN-102352392-B | Chemical-enzyme method for preparing D-tyrosine | UNIV CHONGQING POSTS & TELECOM | 2013-11-06 | — | — | CN | disclosed |
| CN-102352392-A | Chemical-enzyme method for preparing D-tyrosine | UNIV CHONGQING POSTS & TELECOM | 2012-02-15 | — | — | CN | disclosed |
| EP-1621546-B1 | Peptide ligands specific to immonoglobulins | TECNOGEN SPA (IT) | 2008-10-29 | — | — | EP | disclosed |
| EP-1621546-A1 | Peptide ligands specific to immonoglobulins | TECNOGEN S.C.P.A. (IT) | 2006-02-01 | — | — | EP | disclosed |
| CN-1235871-C | Process for preparing D-tyrosine | UNIV NINGBO TECHNOLOGY (CN) | 2006-01-11 | — | — | CN | disclosed |
| CN-1569818-A | Process for preparing D-tyrosine | UNIV NINGBO TECHNOLOGY (CN) | 2005-01-26 | — | — | CN | disclosed |